Vktx nasdaq
Viking Therapeutics Description. Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and ...View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...(NASDAQ: VKTX) Viking Therapeutics's market cap is $978.28M, as of Nov 12, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Viking Therapeutics 's market cap is calculated by multiplying VKTX 's current stock price of $9.78 by VKTX 's total outstanding shares of 100,028,953 .
Did you know?
Standing squarely in the bull camp, BTIG analyst Justin Zelin rates VKTX a Buy along with a $20 price target. This target puts the upside potential at a whopping 221%. This target puts the upside ...Principal Financial Group Inc. bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing ...Strong Quarter-End Cash Position of $393M. SAN DIEGO, July 26, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the ...VIKING THERAPEUTICS INC ( VKTX) is a small-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 94% based on the firm’s underlying fundamentals and the stock ...Find the latest dividend history for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $260.295. $173.46. -0.64. $8.11 +0.06. Macy's Inc ...Find the latest Earnings Report Date for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play.Dec 1, 2023 · Viking Therapeutics last announced its quarterly earnings data on October 25th, 2023. The biotechnology company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.01. Viking Therapeutics has generated ($0.93) earnings per share over the last year ( ($0.93) diluted earnings per share). Dec 4, 2023 · The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on December 4, 2023.The analyst firm set a price target for $32.00 expecting VKTX to rise to within ... The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...Back to VKTX Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.May 16 (Reuters) - Viking Therapeutics Inc VKTX.O said on Tuesday its experimental drug, VK2809, met the main goal of a mid-stage trial to treat patients with a type of fatty liver disease.VKTX soared on obesity data, while Incyte INCY suffered a setback for ruxolitinib extended-release ... The Nasdaq Biotechnology Index has gained 0.68% in the past five trading sessions. Among the ...Fintel reports that on April 27, 2023, HC Wainwright & Co. maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation. Analyst Price Forecast Suggests 41.39% Upside. As of ...Viking Therapeutics Inc stock price (VKTX) NASDAQ: VKTX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Viking Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.For Viking Therapeutics (NASDAQ: VKTX) that’VKTX-3.57%. MDGL -0.85%. SPX-0.20% ... Real-time last sa VKTX Overview Stock Screener Earnings Calendar Sectors Nasdaq | VKTX U.S.: Nasdaq Viking Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 20, 2023 7:59...During the last session, Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares were 1.77 million, with the beta value of the company hitting 0.59. At the end of the trading day, the stock’s price was $12.22, reflecting an intraday gain of 3.30% or $0.39. The 52-week high for the VKTX share is $ ... The three major U.S. stock exchanges are the New York St Get the latest Madrigal Pharmaceuticals Inc (MDGL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Clinical-stage biotech Viking Therapeutics (NASDAQ:VKTX) added ~39% pre-market Tuesday after announcing that its obesity candidate VK2735 led to an average body weight reduction of up to ~8% in a ... Viking Therapeutics, Inc. Common Stock (VKTX) Pre-Market
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered the stock in the […]Dec 1, 2023 · 9 brokers have issued 1 year target prices for Viking Therapeutics' shares. Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. Dec 4, 2023 · The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on December 4, 2023.The analyst firm set a price target for $32.00 expecting VKTX to rise to within ... Fiscal Q3 2023 ended 9/30/23. Reported on 10/25/23. Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to …
Average portfolio weight of all funds dedicated to VKTX is 0.02%, a decrease of 20.95%. Total shares owned by institutions decreased in the last three months by 1.25% to 27,896K shares.Viking Therapeutics, Inc. (NASDAQ:NASDAQ:VKTX) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ETCompany ParticipantsStephanie Diaz - Manager of...…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. May 16, 2023 · May 16 (Reuters) - Viking Therapeutics Inc VKTX.O . Possible cause: Of the funds tracked by Insider Monkey, Peter S. Park's Park West Asse.
seekingalpha.com - August 22 at 1:56 AM. Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Bought by Barclays PLC. marketbeat.com - August 15 at 5:09 AM. Viking Therapeutics stock gets boost from positive news that obesity drugs reduced risk of heart attacks and strokes. msn.com - August 9 at 6:40 PM.VKTX Viking Therapeutics Inc Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021
Back to VKTX Overview. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ...Nasdaq Futures. 15,979.75 ... (NASDAQ:VKTX), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the …In trading on Tuesday, shares of Viking Therapeutics Inc (Symbol: VKTX) entered into oversold territory, hitting an RSI reading of 25.3, after changing hands as low as $15.06 per share. By ...
Viking Therapeutics (NASDAQ: VKTX) is one of the more exciting bi Dec 6, 2021 · Viking Therapeutics, Inc. (VKTX) has been on a downward spiral lately with significant selling pressure. After declining 24.8% over the past four weeks, the stock looks well positioned for a trend ... VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83. Morphic Holding Inc. 23.40. +0.29. +1.25%. Get Viking TheraMar. 28, 2023, 08:37 AM. Viking Therapeutics Inc (NASDAQ:VKTX) s Aug 24, 2023 · Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Viking Therapeutics Inc (Symbol: VKTX), where a total of 11,518 contracts have traded ... Below is a chart showing VKTX's trailing twelve month trad Viking Therapeutics (NASDAQ: VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of VK2735. VK2735 is a dual glucagon-like peptide 1 (GLP-1) and “glucose ... Viking Therapeutics, Inc. ("Viking"Nasdaq Data provided by Nasdaq Data Link, a premier soIn a report released yesterday, Steven Seedhouse from Raymond James Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.The Nasdaq Composite ... (VKTX 6.23%), whose shares jumped 48%. Viking is looking at a NASH treatment that could use an approach similar to that of Madrigal's candidate, and while Viking's drug is ... The Nasdaq Composite ... (VKTX 6.23%), whose shares jumped 48% About Institutional Holdings. Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and ... Of the funds tracked by Insider Monkey, Peter S. Park's Park West Asset Management has the largest position in Viking Therapeutics, Inc. (NASDAQ:VKTX), worth close to $12 million, accounting for 0 ... Shares of Viking Therapeutics ( VKTX 6.23%) were up[Viking Therapeutics Inc (NASDAQ:VKTX) shares are Mar 19, 2023 · VIKING THERAPEUTICS INC ( VKTX) is a small-cap va Strong Quarter-End Cash Position of $376M. SAN DIEGO, Oct. 25, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the ...